Electromed (NYSE:ELMD) Releases Earnings Results, Beats Estimates By $0.13 EPS

Electromed (NYSE:ELMD) posted its quarterly earnings data on Tuesday. The company reported $0.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.03 by $0.13, Zacks reports. Electromed had a return on equity of 15.32% and a net margin of 11.34%. The firm had revenue of $14.67 million for the quarter.

Electromed Stock Performance

Shares of ELMD stock traded up $0.03 during trading on Friday, hitting $28.92. 52,112 shares of the company were exchanged, compared to its average volume of 41,564. The firm has a market capitalization of $244.66 million, a price-to-earnings ratio of 40.11 and a beta of 0.27. The business’s 50-day simple moving average is $21.67 and its 200 day simple moving average is $17.65. Electromed has a twelve month low of $9.81 and a twelve month high of $30.00.

About Electromed

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.